Trial reportBMC women's health2024
Evaluating the safety and efficacy of wormwood vaginal cream on sexual satisfaction and quality of sexual life of postmenopausal women: a randomized, triple-blinds, placebo-controlled clinical trial.
Trial report in BMC women's health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe physical and mental changes created during menopause cause sexual dysfunction, which affects the quality of life, self-esteem, and emotional relationships. Wormwood cream contains tannins, terpenoids, flavonoids, phytosterols, and alkaloids. The purpose of this study is to evaluate the safety and effectiveness of wormwood vaginal cream on the sexual satisfaction and quality of sexual life of postmenopausal women.
methodThis study was a randomized, triple-blind, placebo-controlled clinical trial conducted on 112 postmenopausal women (45-65 years old) in 2021. The studied women were randomly assigned to two wormwood cream or placebo groups. Wormwood cream or placebo was used for 4 weeks and 3 times a week. The main data collection tools included the Larson Sexual Satisfaction Questionnaire (LSSQ) and the Sexual Quality of Life Questionnaire (SQOL-F). SPSS software version 26 and independent t, Mann-Whitney, paired t and Wilcoxon tests were used for statistical analysis. P < 0.05 was considered significant.
resultsBefore the intervention, the mean and standard deviation of sexual satisfaction was 73.57 ± 3.84 in the intervention group and 73.16 ± 4.52 in the placebo group. After the intervention, the mean and standard deviation of sexual satisfaction in the intervention group was 75.34 ± 3.85 and in the placebo group was 72.82 ± 4.32. The quality of women's sexual life before of the intervention in the intervention and placebo groups was 59.16 ± 14.10 and 57.18 ± 12.38, and after the intervention, it was 83.00 ± 11.51and 69.64 ± 12.97, respectively. At the end of 4 weeks, participants in the wormwood cream group showed a significant improvement in sexual satisfaction and the quality of women's sexual life (P < 0.001). It was meaningful.
conclusionBased on the findings of this trial, wormwood vaginal cream can be used as an uncomplicated topical supplement to improve sexual satisfaction and quality of sexual life in postmenopausal women with low sexual satisfaction and quality of sexual life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.